Operating profit/loss (EBIT) of Sobi 2008-2018

the Swedish biopharmaceutical company Sobi had negative EBIT during the period from 2011 to 2014. The following years, the EBIT increased significantly, and in 2018 Sobi's operating profit was around three billion Swedish kronor.

Operating profit/loss (EBIT) of Sobi from 2008 to 2018

Operating profit in SEK
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2019



Survey time period

2008 to 2018

Supplementary notes

Sobi (Swedish Orphan Biovitrum) is a Swedish biopharmaceutical company founded in 2001. The company produces biopharmaceuticals aimed to treat rare diseases.

Some figures are taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.